Malaria vaccine

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 39/002 (2006.01) C07K 14/445 (2006.01) A61K 39/00 (2006.01)

Patent

CA 2359610

The present invention relates to a vaccine against malaria comprising a polypeptide having the amino acid sequence of the C-terminal part of the circumsporozoite protein of a Plasmodium species, in which polypeptide one or more pairs of cysteine residues are oxidized, and optionally a suitable carrier and/or adjuvant and/or biodegradable microcapsules for use in humans.

L'invention concerne un vaccin contre la malaria, qui comporte un polypeptide contenant la séquence d'acides aminés de la partie C-terminale de la protéine circumsporozoïtique d'un <u>Plasmodium</u>, ce polypeptide contenant une ou plusieurs paires de résidus cystéine oxydés, et éventuellement un excipient et/ou un adjuvant approprié(s) et/ou des microcapsules biodégradables pour un usage chez l'être humain.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Malaria vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Malaria vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Malaria vaccine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1727527

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.